John Shannon
Vermögen: 9 Mio $ am 31.05.2026
Vermögen: 9 Mio $ am 31.05.2026
John Patrick Shannon currently works at Xeris Biopharma Holdings, Inc., as Chief Executive Officer & Director from 2024.
Mr. Shannon also formerly worked at Catheter Connections, Inc., as Chief Executive Officer & Director from 2015 to 2016, Viatris Holdings LLC, as Executive Director-Cardiovascular Global, Baxter Healthcare Corp., as GM-Global Hemophilia & Commercial Excellence, Xeris Pharmaceuticals, Inc., as President & Chief Operating Officer from 2020 to 2021, Bock Pharmacal Co., as Head-Sales Operations, Marketing & Strategic, Baxter BioScience Corp., as Vice President & General Manager from 2002 to 2012, Caremark LLC, as Vice President-Marketing, and Durata Therapeutics, Inc., as Chief Commercial Officer from 2012 to 2014.
Mr. Shannon received his undergraduate degree from Western Illinois University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.04.2026 | 1.507.143 ( 0,87 % ) | 9 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| XERIS BIOPHARMA HOLDINGS, INC. | Vorstandsvorsitzender | 01.08.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Develops vascular access products | Vorstandsvorsitzender | 01.01.2016 |
| DURATA THERAPEUTICS INC | Corporate Officer/Principal | 01.11.2014 |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Corporate Officer/Principal | 01.01.2012 |
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Corporate Officer/Principal | 01.01.2011 |
Viatris Holdings LLC
Viatris Holdings LLC Pharmaceuticals: MajorHealth Technology Produces noncommunicable and infectious diseases therapeutic medicines | Corporate Officer/Principal | 01.01.2001 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 10 |
|---|---|
Baxter Healthcare Corp.
Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Develops, manufactures and distributes hospital supplies and medical technologies | Health Technology |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ready-to-use and liquid-stable injectables | Health Technology |
Catheter Connections, Inc.
Catheter Connections, Inc. Medical SpecialtiesHealth Technology Develops vascular access products | Health Technology |
Bock Pharmacal Co.
Bock Pharmacal Co. Miscellaneous Commercial ServicesCommercial Services Wholesale pharmaceutical packaging and distribution | Commercial Services |
Western Illinois University
Western Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baxter BioScience Corp.
Baxter BioScience Corp. BiotechnologyHealth Technology Provides biopharmaceutical and vaccines services | Health Technology |
Viatris Holdings LLC
Viatris Holdings LLC Pharmaceuticals: MajorHealth Technology Produces noncommunicable and infectious diseases therapeutic medicines | Health Technology |
Caremark LLC | |
Durata Therapeutics, Inc.
Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel therapeutics for infectious diseases and acute illnesses | Health Technology |
Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen